Colistin plus meropenem for carbapenem-resistant Gram-negative infections: in vitro synergism is not associated with better clinical outcomes
- Resource Type
- Article
- Authors
- Paul, Mical; Benattar, Yael Dishon; Dickstein, Yaakov; Bitterman, Roni; Zayyad, Hiba; Koppel, Fidi; Zak-Doron, Yael; Altunin, Sergey; Andria, Nizar; Neuberger, Ami; Stern, Anat; Petersiel, Neta; Raines, Marina; Karban, Amir; Leibovici, Leonard; Yahav, Dafna; Eliakim-Raz, Noa; Zusman, Oren; Elbaz, Michal; Atamna, Heyam; Daitch, Vered; Babich, Tanya; Carmeli, Yehuda; Nutman, Amir; Adler, Amos; Levi, Inbar; Daikos, George L.; Skiada, Anna; Pavleas, Ioannis; Antoniadou, Anastasia; Kotsaki, Antigoni; Durante-Mangoni, Emanuele; Andini, Roberto; Iossa, Domenico; Bernardo, Mariano; Cavezza, Giusi; Bertolino, Lorenzo; Giuffre, Giuseppe; Giurazza, Roberto; Cuccurullo, Susanna; Galdo, Maria; Murino, Patrizia; Cristinziano, Adriano; Corcione, Antonio; Zampino, Rosa; Pafundi, Pia Clara; Mouton, Johan; Friberg, Lena; Kristoffersson, Anders; Theuretzbacher, Ursula; Lellouche, Jonathan; Temkin, Elizabeth; Daikos, George; Dishon-Benattar, Yael; Friberg, Lena E.; Mouton, Johan W.
- Source
- In Clinical Microbiology and Infection September 2020 26(9):1185-1191
- Subject
- Language
- ISSN
- 1198-743X